An Interplay of S-Nitrosylation and Metal Ion Binding for Astrocytic S100B Protein

Mammalian S100B protein plays multiple important roles in cellular brain processes. The protein is a clinically used marker for several pathologies including brain injury, neurodegeneration and cancer. High levels of S100B released by astrocytes in Down syndrome patients are responsible for reduced neurogenesis of neural progenitor cells and induction of cell death in neurons. Despite increasing understanding of S100B biology, there are still many questions concerning the detailed molecular mechanisms that determine specific activities of S100B. Elevated overexpression of S100B protein is often synchronized with increased nitric oxide-related activity. In this work we show S100B is a target of exogenous S-nitrosylation in rat brain protein lysate and identify endogenous S-nitrosylation of S100B in a cellular model of astrocytes. Biochemical studies are presented indicating S-nitrosylation tunes the conformation of S100B and modulates its Ca2+ and Zn2+ binding properties. Our in vitro results suggest that the possibility of endogenous S-nitrosylation should be taken into account in the further studies of in vivo S100B protein activity, especially under conditions of increased NO-related activity.

[1]  Leonardo Nogueira,et al.  Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture , 2009, Nature Biotechnology.

[2]  R. Gaynor,et al.  S100 PROTEIN: A MARKER FOR HUMAN MALIGNANT MELANOMAS? , 1981, The Lancet.

[3]  Hong Li,et al.  Functional proteomics approaches for the identification of transnitrosylase and denitrosylase targets. , 2013, Methods.

[4]  Igor Zhukov,et al.  Post-translational S-Nitrosylation Is an Endogenous Factor Fine Tuning the Properties of Human S100A1 Protein* , 2012, The Journal of Biological Chemistry.

[5]  R. Donato,et al.  S100B protein in tissue development, repair and regeneration. , 2013, World journal of biological chemistry.

[6]  P. Vallance,et al.  S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: Further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Zenon Grabarek,et al.  Structural basis for diversity of the EF-hand calcium-binding proteins. , 2006, Journal of molecular biology.

[8]  David J Weber,et al.  Solution structure of calcium-bound rat S100B(betabeta) as determined by nuclear magnetic resonance spectroscopy,. , 1998, Biochemistry.

[9]  M. Raftery,et al.  Oxidative modifications of S100 proteins: functional regulation by redox , 2009, Journal of leukocyte biology.

[10]  S. Lipton,et al.  Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases , 2011, Cell Death and Differentiation.

[11]  David J Weber,et al.  S100 proteins in cancer , 2015, Nature Reviews Cancer.

[12]  G. Makhatadze,et al.  Thermodynamic and kinetic analysis of peptides derived from CapZ, NDR, p53, HDM2, and HDM4 binding to human S100B. , 2012, Biochemistry.

[13]  J. Stamler,et al.  Assessment and Application of the Biotin Switch Technique for Examining Protein S-Nitrosylation under Conditions of Pharmacologically Induced Oxidative Stress* , 2007, Journal of Biological Chemistry.

[14]  Guanghui Wang,et al.  Characterization of potential S-nitrosylation sites in the myocardium. , 2011, American journal of physiology. Heart and circulatory physiology.

[15]  Paul Tempst,et al.  Protein S-nitrosylation: a physiological signal for neuronal nitric oxide , 2001, Nature Cell Biology.

[16]  Callaway Cw,et al.  Letter: Diabetic ketoacidosis. , 1974, Lancet.

[17]  K. Haglid,et al.  Zinc ion binding to human brain calcium binding proteins, calmodulin and S100b protein. , 1983, Biochemical and biophysical research communications.

[18]  C. Chen,et al.  Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells , 2014, Nature Communications.

[19]  Jeffrey D. Zaremba,et al.  S-nitrosylation-mediated redox transcriptional switch modulates neurogenesis and neuronal cell death. , 2014, Cell reports.

[20]  R. Mrak,et al.  The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer’s disease , 2001, Neurobiology of Aging.

[21]  J. Baudier,et al.  Ions binding to S100 proteins. II. Conformational studies and calcium-induced conformational changes in S100 alpha alpha protein: the effect of acidic pH and calcium incubation on subunit exchange in S100a (alpha beta) protein. , 1986, Journal of Biological Chemistry.

[22]  R. Donato,et al.  S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond , 2010, Cardiovascular psychiatry and neurology.

[23]  J. Stamler,et al.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Niedzwiecka,et al.  Structural changes of eIF4E upon binding to the mRNA 5' monomethylguanosine and trimethylguanosine Cap. , 2008, Biochemistry.

[25]  J. Stamler,et al.  Basal and Stimulated Protein S-Nitrosylation in Multiple Cell Types and Tissues* , 2002, The Journal of Biological Chemistry.

[26]  A. Holmgren,et al.  Regulation of the Catalytic Activity and Structure of Human Thioredoxin 1 via Oxidation and S-Nitrosylation of Cysteine Residues* , 2008, Journal of Biological Chemistry.

[27]  S. Hazen,et al.  Target-Selective Protein S-Nitrosylation by Sequence Motif Recognition , 2014, Cell.

[28]  J. Stamler,et al.  Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Barger,et al.  Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues , 1989, The Journal of cell biology.

[30]  R. Donato,et al.  S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. , 2004, Biochimica et biophysica acta.

[31]  M. Lalowski,et al.  Global Analysis of S-nitrosylation Sites in the Wild Type (APP) Transgenic Mouse Brain-Clues for Synaptic Pathology * , 2014, Molecular & Cellular Proteomics.

[32]  Fabien Campagne,et al.  SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures. , 2006 .

[33]  W. Maret,et al.  The zinc/thiolate redox biochemistry of metallothionein and the control of zinc ion fluctuations in cell signaling. , 2007, Archives of biochemistry and biophysics.

[34]  D. Marshak,et al.  Characterization of Human Brain S100 Protein Fraction: Amino Acid Sequence of S100β , 1985, Journal of neurochemistry.

[35]  Kate S. Carroll,et al.  Cysteine-Mediated Redox Signaling: Chemistry, Biology, and Tools for Discovery , 2013, Chemical reviews.

[36]  Stuart A. Lipton,et al.  Aberrant Protein S-Nitrosylation in Neurodegenerative Diseases , 2013, Neuron.

[37]  C. Kay,et al.  Hydrodynamic properties of bovine brain S‐100 proteins , 1984, FEBS letters.

[38]  L. J. Eldik,et al.  S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia , 2001, Neurochemistry International.

[39]  J. Baudier,et al.  Ions binding to S100 proteins: structural changes induced by calcium and zinc on S100a and S100b proteins. , 1983, Biochemistry.

[40]  Hugo M. Botelho,et al.  Natural and amyloid self‐assembly of S100 proteins: structural basis of functional diversity , 2010, The FEBS journal.

[41]  David J Weber,et al.  Solution structure of zinc- and calcium-bound rat S100B as determined by nuclear magnetic resonance spectroscopy. , 2005, Biochemistry.

[42]  Jennifer E Van Eyk,et al.  Chasing Cysteine Oxidative Modifications: Proteomic Tools for Characterizing Cysteine Redox Status , 2012, Circulation. Cardiovascular genetics.

[43]  C. Heizmann,et al.  The crystal structures of human S100B in the zinc- and calcium-loaded state at three pH values reveal zinc ligand swapping. , 2011, Biochimica et biophysica acta.

[44]  R. Cuomo,et al.  The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. , 2006, Life sciences.

[45]  R. Donato,et al.  Functions of S100 proteins. , 2012, Current molecular medicine.

[46]  Laura E. Thompson,et al.  The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography. , 2010, Journal of molecular biology.

[47]  P. Schoenknecht,et al.  Serum S100B Represents a New Biomarker for Mood Disorders , 2013, Current drug targets.

[48]  J. Cox,et al.  Ion-binding properties of recombinant S100beta and two derivatives with either an inactivated Ca2+ site II or a normalized Ca2+ site I. , 1997, Biochimica et biophysica acta.

[49]  David J Weber,et al.  The use of dipolar couplings for determining the solution structure of rat apo‐S100B(ββ) , 2008, Protein science : a publication of the Protein Society.

[50]  S. Linse Calcium binding to proteins studied via competition with chromophoric chelators. , 2002, Methods in molecular biology.

[51]  P. Karplus,et al.  Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers , 1998, Nature Structural Biology.

[52]  C. Bernardini,et al.  The S100B protein in biological fluids: more than a lifelong biomarker of brain distress , 2012, Journal of neurochemistry.

[53]  G. Poon,et al.  An explicit formulation approach for the analysis of calcium binding to EF-hand proteins using isothermal titration calorimetry. , 2013, Biophysical journal.

[54]  A. Fersht,et al.  Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53. , 2009, Journal of molecular biology.

[55]  David J Weber,et al.  The Calcium-Dependent Interaction of S100B with Its Protein Targets , 2010, Cardiovascular psychiatry and neurology.

[56]  David J Weber,et al.  The evolution of S100B inhibitors for the treatment of malignant melanoma. , 2013, Future medicinal chemistry.

[57]  Ryan S. Udan,et al.  Location of the Zn2+-Binding Site on S100B As Determined by NMR Spectroscopy and Site-Directed Mutagenesis , 2003 .

[58]  Gert Vriend,et al.  YASARA View—molecular graphics for all devices—from smartphones to workstations , 2014, Bioinform..

[59]  Y. Mély,et al.  Intra‐ and Interchain Disulfide Bond Generation in S100b Protein , 1990, Journal of neurochemistry.

[60]  C. Gottfried,et al.  S100B content and secretion decrease in astrocytes cultured in high-glucose medium , 2007, Neurochemistry International.

[61]  P. Hernansanz-Agustín,et al.  Specificity in S-nitrosylation: a short-range mechanism for NO signaling? , 2013, Antioxidants & redox signaling.

[62]  F. D'armiento,et al.  Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease. , 2007, Gastroenterology.

[63]  A. Wysłouch-Cieszyńska,et al.  Redox modifications of the C-terminal cysteine residue cause structural changes in S100A1 and S100B proteins. , 2004, Biochimica et biophysica acta.

[64]  R. Donato,et al.  S100b expression in and effects on microglia , 2001, Glia.

[65]  K. Khoo,et al.  Cysteine S-Nitrosylation Protects Protein-tyrosine Phosphatase 1B against Oxidation-induced Permanent Inactivation* , 2008, Journal of Biological Chemistry.

[66]  Eva Thulin,et al.  The EF‐hand domain: A globally cooperative structural unit , 2002, Protein science : a publication of the Protein Society.

[67]  J. Shepherd,et al.  A direct spectrophotometric method for the simultaneous determination of zinc and cobalt in metalloproteins using 4-(2-pyridylazo)resorcinol. , 2009, Analytical biochemistry.

[68]  J. Poznański,et al.  HEW lysozyme salting by high-concentration NaCl solutions followed by titration calorimetry. , 2005, Biophysical chemistry.

[69]  D. Souza,et al.  Increased serum S100B protein in schizophrenia: a study in medication-free patients. , 2001, Journal of psychiatric research.

[70]  K. Hess,et al.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease , 2006, Neurology.

[71]  A. Krężel,et al.  Molar absorption coefficients and stability constants of metal complexes of 4-(2-pyridylazo)resorcinol (PAR): Revisiting common chelating probe for the study of metalloproteins. , 2015, Journal of inorganic biochemistry.

[72]  J. Poznański,et al.  Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin. , 2009, Journal of inorganic biochemistry.